南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2010年
3期
538-540
,共3页
刘清%罗永胜%耿岚%王伟%赖卓胜%李富荣
劉清%囉永勝%耿嵐%王偉%賴卓勝%李富榮
류청%라영성%경람%왕위%뢰탁성%리부영
凋亡素基因%腺病毒载体%ADM%CDDP%肝细胞癌
凋亡素基因%腺病毒載體%ADM%CDDP%肝細胞癌
조망소기인%선병독재체%ADM%CDDP%간세포암
apoptin gene%adenovirus vector%hepatocellular carcinoma%ADM%CDDP
目的 探讨腺病毒介导凋亡素基因联合阿霉素(ADM)与顺铂(CDDP)对种植性肝癌的治疗.方法 建立c57BL/6小鼠皮下荷肝细胞癌模型(n=64),计算成瘤率,观察肿瘤内注射含凋亡素基因的重组腺病毒、ADM及CDDP后种植瘤的体积变化、毒副作用和组织学变化,同时计算抑瘤率.结果 在治疗7d后腺病毒AdAFPvp3联合ADM与CDDP治疗组的种植瘤体积、重量均显著低于对照组,比较差异均具有统计学意义,在治疗期间没有观察到毒副作用.结论 携带凋亡素基因的重组腺病毒联合ADM与CDDP对肝细胞癌具有治疗作用.
目的 探討腺病毒介導凋亡素基因聯閤阿黴素(ADM)與順鉑(CDDP)對種植性肝癌的治療.方法 建立c57BL/6小鼠皮下荷肝細胞癌模型(n=64),計算成瘤率,觀察腫瘤內註射含凋亡素基因的重組腺病毒、ADM及CDDP後種植瘤的體積變化、毒副作用和組織學變化,同時計算抑瘤率.結果 在治療7d後腺病毒AdAFPvp3聯閤ADM與CDDP治療組的種植瘤體積、重量均顯著低于對照組,比較差異均具有統計學意義,在治療期間沒有觀察到毒副作用.結論 攜帶凋亡素基因的重組腺病毒聯閤ADM與CDDP對肝細胞癌具有治療作用.
목적 탐토선병독개도조망소기인연합아매소(ADM)여순박(CDDP)대충식성간암적치료.방법 건립c57BL/6소서피하하간세포암모형(n=64),계산성류솔,관찰종류내주사함조망소기인적중조선병독、ADM급CDDP후충식류적체적변화、독부작용화조직학변화,동시계산억류솔.결과 재치료7d후선병독AdAFPvp3연합ADM여CDDP치료조적충식류체적、중량균현저저우대조조,비교차이균구유통계학의의,재치료기간몰유관찰도독부작용.결론 휴대조망소기인적중조선병독연합ADM여CDDP대간세포암구유치료작용.
Objective To study the therapeutic effect adenovirus-mediated apoptin gene transfer combined with ADM and CDDP on hepatocellular carcinoma in mice. Methods In c57BL/6 mice bearing hepatocellular carcinoma, the changes of tumor volume, histomorphology, tumor inhibition rate and the side effects were observed after intratumoral injection of adenovirus containing apoptin gene and ADM and CDDP. Results Seven days after the treatment, the mean volume of the tumor in the mice receiving intratumoral apoptin-containing adenovirus injection combined with ADM and CDDP reduced significantly as compared with that in mice treated with adenovirus vehicle and control group. The tumor inhibition rate in the combined treatment group was 90.13%, significantly higher than that in the control group. No adverse effect of the treat was observed in the course of the experiment. Conclusion The adenoviras vectors containing apoptin gene combined with ADM and CDDP may serve a safe treatment of hepatocellular carcinoma.